Four practices. Each ends in a document you can act on.

Redesign of a business to a defined performance target: portfolio choices, organisation and operating model, asset footprint and the turnaround plan for the assets that stay. I design it and I stay through implementation.

Eight to sixteen weeks. Baseline and diagnostic, options with a quantified business case for each, a recommendation to the board, then a programme office through the first phase of delivery.

• Performance baseline and value-gap analysis by business and asset
• Portfolio and organisation options with financials (DCF, EBITDA bridge)
• Board recommendation and decision paper
• Implementation plan, PMO set-up and change-management approach

Corporate strategy of a global polymers producer designed to deliver an additional $3 bn EBITDA, with the reorganisation from product-push to market-pull. European turnaround: €450 m improvement, two asset closures. PMO lead for two global transformation programmes (2015 and 2017-18).

Origination and execution of transactions: target and partner screening, valuation, business and technology due diligence, deal structure and term sheet, anti-trust, and post-merger integration or standalone carve-out.

Follows the deal. A two-week screen or valuation; a six-to-ten-week due diligence with a negotiation mandate; or an integration programme over several months.

• Screening memo and shortlist with strategic fit and synergy map
• Valuation (DCF and multiples) with risk register
• Due-diligence report: business, technology, engineering, finance, tax, HR, HSE
• Term sheet and negotiation plan; integration or separation blueprint

Due diligence and integration of a $4 bn petrochemical asset portfolio, including synergy identification and delivery. A $1.25 bn metallocene polyethylene technology and manufacturing joint venture led end-to-end, from technology valuation to anti-trust filing and board approval. Twenty-five joint ventures evaluated or signed across the Gulf, Russia, Central Asia, India, China and the US; see the transaction map.

Licensor benchmarking and selection, review and mark-up of licence and engineering term sheets, feedstock and off-take structuring, and negotiation strategy, with the licensor's economics understood from the inside.

Runs alongside the project: RFI and licensor comparison in four to six weeks; term-sheet reviews and negotiation briefs as each agreement comes up; a lender-ready technology and feedstock case for financing.

• Licensor RFI package and head-to-head technology comparison
• Licence, engineering and feedstock term-sheet reviews with proposed positions
• Negotiation brief: objectives, fall-backs, precedents from signed agreements
• Technology and feedstock case for lenders and development finance institutions

More than twenty technologies accessed through eleven partners for a $10 bn diversification programme: C8-mLLDPE, POE, POP, EO derivatives, MDI, TDI, polyols, carbon fibre. 2026: full licensor programme and feedstock term-sheet work for a US$5 bn greenfield ethane-based complex on a development-finance timeline.

An independent operator's view of the asset: commercial and technology due diligence, standalone-cost and carve-out assessment, valuation, synergies and risks, and a clear investment recommendation to the committee.

Fits the process timetable: a red-flag review in one to two weeks for a non-binding offer; a full commercial and technical due diligence in four to six weeks for the binding phase.

• Red-flag memo for the indicative bid
• Commercial and technology due-diligence report
• Valuation with standalone costs, synergies and downside cases
• Investment-committee paper with a recommendation and conditions

A European polyolefins business ($500 m) and a global engineering-thermoplastics business ($450 m): buy-side due diligence, valuation, carve-out and standalone-cost assessment and investment recommendations for private-equity funds, 2023-2026. Independent advisor to private-equity investment committees since founding Chem Reset.